LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 4.71 | 771.67 | 1010 | 956 | 1.0561 | 1.3854 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 6.94 | 771.67 | 923 | 1045 | 0.8832 | 0.5056 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 6.94 | 771.67 | 1037 | 1045 | 0.9922 | 0.9647 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 6.94 | 771.67 | 1091 | 1045 | 1.0439 | 1.2063 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 9.16 | 771.67 | 1016 | 1138 | 0.8924 | 0.6327 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 9.16 | 771.67 | 1101 | 1138 | 0.9671 | 0.8841 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 9.16 | 771.67 | 1222 | 1138 | 1.0733 | 1.2689 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.56 | 771.67 | 1130 | 1280 | 0.8824 | 0.6853 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.56 | 771.67 | 1236 | 1280 | 0.9652 | 0.9053 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.56 | 771.67 | 1320 | 1280 | 1.0307 | 1.0846 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 13.78 | 771.67 | 1194 | 1459 | 0.8180 | 0.6074 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 13.78 | 771.67 | 1378 | 1459 | 0.9440 | 0.8785 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 13.78 | 771.67 | 1485 | 1459 | 1.0173 | 1.0376 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.00 | 771.67 | 1254 | 1585 | 0.7909 | 0.5958 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.00 | 771.67 | 1421 | 1585 | 0.8963 | 0.7999 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.00 | 771.67 | 1546 | 1585 | 0.9751 | 0.9520 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.22 | 771.67 | 1309 | 1741 | 0.7517 | 0.5684 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.22 | 771.67 | 1477 | 1741 | 0.8482 | 0.7383 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.22 | 771.67 | 1608 | 1741 | 0.9234 | 0.8688 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.44 | 771.67 | 1356 | 1910 | 0.7096 | 0.5387 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.44 | 771.67 | 1543 | 1910 | 0.8075 | 0.6984 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.44 | 771.67 | 1699 | 1910 | 0.8891 | 0.8282 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 22.66 | 771.67 | 1423 | 2141 | 0.6645 | 0.5153 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 22.66 | 771.67 | 1613 | 2141 | 0.7532 | 0.6499 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 22.66 | 771.67 | 1729 | 2141 | 0.8074 | 0.7295 | MN20160304_L01 | L08 |